Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Oesophagogastric Cancer × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 118 Stomach Neoplasms 100 Carcinoma, Hepatocellular 66 Rectal Neoplasms 55 Esophageal Neoplasms 47 Pancreatic Neoplasms 45 Colonic Neoplasms 43 Neoplasms 23 Neoplasm Metastasis 18 Gastrointestinal Neoplasms 18 Esophageal Squamous Cell Carcinoma 18 Cholangiocarcinoma 12 Liver Neoplasms 11 Breast Neoplasms 11 Barrett Esophagus 9 Adenoma 8 Motor Activity 7 Lung Neoplasms 7 Liver Cirrhosis 7 Digestive System Neoplasms 7 Adenomatous Polyposis Coli 6 Hypertension, Portal 5 Colonic Polyps 5 Biliary Tract Neoplasms 5 Uterine Cervical Neoplasms 4 Surgical Wound Infection 4 Sarcopenia 4 Sarcoma 4 Postoperative Complications 4 Polyps 4

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡